BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7980517)

  • 1. Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells.
    Sato F; Matsukawa Y; Matsumoto K; Nishino H; Sakai T
    Biochem Biophys Res Commun; 1994 Oct; 204(2):578-84. PubMed ID: 7980517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
    Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF
    Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein arrests cell cycle progression at G2-M.
    Matsukawa Y; Marui N; Sakai T; Satomi Y; Yoshida M; Matsumoto K; Nishino H; Aoike A
    Cancer Res; 1993 Mar; 53(6):1328-31. PubMed ID: 8443813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines.
    Wang W; VanAlstyne PC; Irons KA; Chen S; Stewart JW; Birt DF
    Nutr Cancer; 2004; 48(1):106-14. PubMed ID: 15203384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes.
    Lepley DM; Li B; Birt DF; Pelling JC
    Carcinogenesis; 1996 Nov; 17(11):2367-75. PubMed ID: 8968050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones.
    Jing Y; Waxman S
    Anticancer Res; 1995; 15(4):1147-52. PubMed ID: 7653993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin.
    Chung CS; Jiang Y; Cheng D; Birt DF
    Mol Carcinog; 2007 Sep; 46(9):773-82. PubMed ID: 17620292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells.
    Panaro NJ; Popescu NC; Harris SR; Thorgeirsson UP
    Br J Cancer; 1999 Aug; 80(12):1905-11. PubMed ID: 10471038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids activate wild-type p53.
    Plaumann B; Fritsche M; Rimpler H; Brandner G; Hess RD
    Oncogene; 1996 Oct; 13(8):1605-14. PubMed ID: 8895505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
    Van Dolah FM; Ramsdell JS
    J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage colony-stimulating factor stimulates growth progression of the G1-phase fraction and induces monocytic differentiation of the G2/M-phase fraction in human myeloid leukemia cells.
    Kato H; Adachi K; Suzuki M; Tanimoto M; Saito H
    Exp Hematol; 1993 Nov; 21(12):1597-604. PubMed ID: 8405241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine overcomes genistein-induced G2/M cell cycle arrest in breast cancer cells.
    Li Z; Liu W; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
    Nutr Cancer; 2008; 60(3):382-8. PubMed ID: 18444173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin.
    Lin JK; Chen YC; Huang YT; Lin-Shiau SY
    J Cell Biochem Suppl; 1997; 28-29():39-48. PubMed ID: 9589348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line.
    Faure R; Vincent M; Dufour M; Shaver A; Posner BI
    J Cell Biochem; 1995 Nov; 59(3):389-401. PubMed ID: 8567756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen causes G2/M arrest and apoptosis in breast cancer cells MDA-MB-231.
    Nomoto S; Arao Y; Horiguchi H; Ikeda K; Kayama F
    Oncol Rep; 2002; 9(4):773-6. PubMed ID: 12066207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.